A Pharmacokinetic Study of the Coadministration of LY2216684 With Sertraline

NCT01250873 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: LY2216684
DRUG: Sertraline

Sponsor

Eli Lilly and Company